Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a prevalent heterogenous genetic cardiac disorder. In the cardiac myosin inhibitor era, the guideline-directed management of HCM remains an emerging frontier worldwide. Septal myectomy has been the gold standard treatment option for obstructive HCM over the past 60 years. However, the complexity of this procedure and required expertise (and lack of qualified training) have limited its success and availability beyond high-volume HCM centers. Transapical beating-heart septal myectomy (TA-BSM), a newly developed innovative technique, simplifies conventional septal myectomy by eliminating the need for sternotomy, cardiopulmonary bypass, and aortotomy. Most important, the inclusion of real-time intraoperative echocardiographic guidance and evaluation makes TA-BSM safer, more precise, cost-effective, and reproducible. The apparent advantages of TA-BSM, including substantial reductions in surgical trauma and operating times and much faster postoperative recovery in patients with obstructive HCM, are encouraging. TA-BSM is particularly feasible in patients with long-segment obstruction, or small aortic valve annulus, or in those who had undergone previous cardiac operations. The frequent resolution of systolic anterior motion and associated mitral regurgitation after TA-BSM, without concomitant mitral valve intervention, highlights the central role of intraoperative echocardiography and close surgeon-echocardiographer collaboration in achieving optimal procedural outcomes. Further multicenter evaluation of TA-BSM will help define its role among septal reduction strategies for patients with obstructive HCM.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2026-11-16
DOI
https://doi.org/10.1161/circulationaha.126.080166
Citations
1
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
3.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy

Song Wan, Xiang Wei, Jing Fang
1 citations
Circulation
Cardiomyopathy and Myosin Studies
3.00
article

Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy

Song Wan, Xiang Wei, Jing Fang
article en
1 citations

Abstract

Hypertrophic cardiomyopathy (HCM) is a prevalent heterogenous genetic cardiac disorder. In the cardiac myosin inhibitor era, the guideline-directed management of HCM remains an emerging frontier worldwide. Septal myectomy has been the gold standard treatment option for obstructive HCM over the past 60 years. However, the complexity of this procedure and required expertise (and lack of qualified training) have limited its success and availability beyond high-volume HCM centers. Transapical beating-heart septal myectomy (TA-BSM), a newly developed innovative technique, simplifies conventional septal myectomy by eliminating the need for sternotomy, cardiopulmonary bypass, and aortotomy. Most important, the inclusion of real-time intraoperative echocardiographic guidance and evaluation makes TA-BSM safer, more precise, cost-effective, and reproducible. The apparent advantages of TA-BSM, including substantial reductions in surgical trauma and operating times and much faster postoperative recovery in patients with obstructive HCM, are encouraging. TA-BSM is particularly feasible in patients with long-segment obstruction, or small aortic valve annulus, or in those who had undergone previous cardiac operations. The frequent resolution of systolic anterior motion and associated mitral regurgitation after TA-BSM, without concomitant mitral valve intervention, highlights the central role of intraoperative echocardiography and close surgeon-echocardiographer collaboration in achieving optimal procedural outcomes. Further multicenter evaluation of TA-BSM will help define its role among septal reduction strategies for patients with obstructive HCM.

CirculationVol. 154(20)
Tongji Hospital (CN), Huazhong University of Science and Technology (CN)
Good health and well-being
Openalex Percentile: Top 16%
Cardiomyopathy and Myosin Studies
3.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon